...

Author name: Kai Chen

Kai is a seasoned finance professional with a quantitative background, uses his broad market experience to provide insightful analysis on the markets, helping investors navigate the complexities of stock trading.

Balanced Portfolio

Balanced Portfolio Recommendation: Switch 2% ResMed (RMD) to Clinuvel Pharmaceuticals Ltd (CUV)

With the recent run in RMD we are looking to bank some profits here at $29 (+20%) while we see further upside in the stock, the risk that further developments in the GLP-1 space could derail this recent run. Particularly a study due from Eli Lily a maker of Zepbound in the next month.

We still prefer exposure in the healthcare space and are recommending a switch of our RMD allocation to Clinuvel (CUV) a skin disease treatment for sufferers of EPP. They are also in Phase 2 of a stroke treatment drug which is looking promising 

Bulls vs. Bears

Bulls vs. Bears: Uranium’s Rising Tide & Middle East Tensions

In this episode of “Bulls vs. Bears,” we examine the rise in Uranium prices, driven by supply constraints and growing energy demands. The discussion includes insights from a CEO on the industry’s future. We also analyze tensions in the Middle East, assessing their impact on global markets. Additionally, the episode covers the Davos World Economic Forum, U.S. bank earnings reports, and trends in agriculture and retail stocks. This comprehensive analysis offers listeners a deep dive into current financial market dynamics.

Scroll to Top
Seraphinite AcceleratorOptimized by Seraphinite Accelerator
Turns on site high speed to be attractive for people and search engines.